| Literature DB >> 32775441 |
Anteneh Belayneh1, Fantahun Molla2.
Abstract
BACKGROUND: Coffee has been the most commercialized food product and most widely consumed stimulant beverage in the world. It is a major source of caffeine which is the most bioactive component of coffee. Although both the United States Department of Agriculture and European Food Safety Authority consider daily intake of coffee which contains 400 mg of caffeine as safe for health, it causes different clinically significant pharmacokinetic interactions with many drugs. The aim of this work was to review the effect of coffee on the pharmacokinetic properties of drugs.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32775441 PMCID: PMC7397437 DOI: 10.1155/2020/7909703
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Chemical composition of a cup coffee (150 ml) made from 7.5 g of coffee powder [5].
| Constitute of coffee | Amount (mg) in 1 cup of coffee |
|---|---|
| Caffeine | 80-170 |
| Protein | 100 |
| Water soluble polysaccharides | 410-432 |
| Saccharose | 13.5 |
| Monosaccharides (glucose and fructose) | 7 |
| Volatile acids (formic acid and acetic acid) | 24 |
| Nonvolatile acids (lactate, pyruvate, tartrate, and citrate) | 27 |
| Chlorogenic acids | 250-292 |
| Lipids | 13.5 |
| Trigonelline | 27 |
| Nicotinic acid | 1.4 |
| Volatile aromatic compounds | 7 |
| Minerals | 240 |
| Others | 460 |
Figure 1Chemical structure of caffeine [2].
Figure 2Complexation mechanism of caffeine with drugs by hydrogen bond (a) and dipole–dipole force (b) [15].
Figure 3Comparing serum thyroxine (T4) level after ingestion of 100 μg levothyroxine (L-T4) with water and with 2 cups of coffee (espresso) in healthy volunteers (redrawn from published paper [6]).
Figure 4Plasma salicylate concentration-time curve after oral administration of 650 mg aspirin alone or in combination with coffee (120 mg caffeine) in a human volunteer study (redrawn from published paper [24]).
Figure 5Plasma concentration-time curve after administration of 2 mg ergotamine tartrate alone or in combination with 200 mg caffeine in rats (redrawn from published paper [23]).
Figure 6Levodopa plasma concentration profile after administration of a single oral dose of levodopa 250 mg alone and with caffeine 200 mg in human volunteers (Redrawn from published paper [25]).
Figure 7Variation of the pharmacokinetic profile when orally administered with ketoprofen alone (3.2 mg/kg) and ketoprofen administered with caffeine (17.8 mg/kg) in rats (redrawn from published paper [27]).
Figure 8Effect of coffee on the levodopa pathway into CNS [9].
List of drugs whose rate of metabolism is slowed by caffeine [8].
| Class of drug | Generic name |
|---|---|
| Antidepressants | Amitriptyline, clomipramine, fluvoxamine, mianserin, and imipramine |
| Antipsychotics | Clozapine, haloperidol, and olanzapine |
| Cardiovascular drugs and anticoagulants | Lidocaine, mexiletine, propafenone, propranolol, triamterene, verapamil, and warfarin |
| Cholinesterase inhibitors | Tacrine |
| Local anesthetic | Ropivacaine |
| Nonsteroidal anti-inflammatory drugs | Methotrexate |
| Quinolones | Pefloxacin |
Figure 9Mean plasma concentration vs. time profiles of paracetamol following the administration of 500 mg paracetamol alone and with 60 mg caffeine on healthy male volunteers (redrawn from published paper [46]).
Summary of the effect of coffee on the pharmacokinetics of some drugs.
| Drugs | The effect of coffee on the PK of drugs | Mechanism | References |
|---|---|---|---|
| Escitalopram oxalate | Decrease absorption | Insoluble complex formation | [ |
| Iron and iron-containing drugs | Decrease absorption | Insoluble complex formation | [ |
| Midazolam | Decrease absorption | Changing pH | [ |
| Phenothiazines and butyrophenone | Decrease absorption | Changing pH | [ |
| Aspirin and felodipine | Increase absorption | Changing pH, increase gastric emptying rate | [ |
| Halofantrine | Increase absorption | Changing pH | [ |
| Ergotamine and levodopa | Increase absorption | Changing pH | [ |
| Thyroxine (T4) | Decrease absorption | Sequestering | [ |
| Vitamin D and calcium | Decrease absorption | Affecting sink condition | [ |
| Glucose | Decrease absorption | Inhibition of the activity of glucose-6-phosphatase | [ |
| Memantine and donepezil | Decrease distribution | By enhancing the tightness of the blood-brain barrier | [ |
| Levodopa | Increase distribution | By inhibiting a metabolizing enzyme at peripheral NS and CNS | [ |
| Clozapine, amitriptyline, lithium, theophylline, warfarin, clomipramine, fluvoxamine, imipramine, haloperidol, olanzapine, lidocaine, mexiletine, propranolol, triamterene, verapamil, ropivacaine, melatonin, dextromethorphan, methotrexate, and pefloxacin | Inhibit metabolism | By saturating a metabolizing enzyme | [ |
| Paracetamol | Enhancing metabolism | Induce the activity of cytochrome P-448 | [ |
| Minerals (calcium, magnesium, sodium, and chloride), water-soluble vitamins (vit B), oxandrolone, and epioxandrolone | Increase excretion | Increasing volume of urine | [ |